MAYEROVA, Lucie, Anna CHALOUPKA, Peter WOHLFAHRT, Jaroslav Alois HUBACEK, Helena BEDANOVA, Zhi CHEN, Josef KAUTZNER, Vojtech MELENOVSKY, Ivan MALEK, Ales TOMASEK, Eva OZÁBALOVÁ, Jan KREJČÍ, Tomas KOVARNIK, Milan SONKA and Michal PAZDERNIK. Role of genetics in the development of cardiac allograft vasculopathy. Bratislava Medical Journal - Bratislavské lekárske listy. BRATISLAVA: Univerzita Komenského, 2023, vol. 124, No 3, p. 193-200. ISSN 0006-9248. Available from: https://dx.doi.org/10.4149/BLL_2023_031.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Role of genetics in the development of cardiac allograft vasculopathy
Authors MAYEROVA, Lucie (203 Czech Republic), Anna CHALOUPKA (203 Czech Republic, belonging to the institution), Peter WOHLFAHRT (203 Czech Republic), Jaroslav Alois HUBACEK (203 Czech Republic), Helena BEDANOVA (203 Czech Republic), Zhi CHEN, Josef KAUTZNER (203 Czech Republic), Vojtech MELENOVSKY (203 Czech Republic), Ivan MALEK (203 Czech Republic), Ales TOMASEK (203 Czech Republic), Eva OZÁBALOVÁ (203 Czech Republic, belonging to the institution), Jan KREJČÍ (203 Czech Republic, belonging to the institution), Tomas KOVARNIK (203 Czech Republic), Milan SONKA (203 Czech Republic) and Michal PAZDERNIK (203 Czech Republic, guarantor).
Edition Bratislava Medical Journal - Bratislavské lekárske listy, BRATISLAVA, Univerzita Komenského, 2023, 0006-9248.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher Slovakia
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.500 in 2022
RIV identification code RIV/00216224:14110/23:00132170
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.4149/BLL_2023_031
UT WoS 000944162900006
Keywords in English cardiac allograft vasculopathy; optical coherence tomography; vascular endothelial growth factor A; intimal thickening; genetic polymorphism
Tags 14110115, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 1/2/2024 12:00.
Abstract
BACKGROUND: The association between genetic polymorphisms and early cardiac allograft vasculopathy (CAV) development is relatively unexplored. Identification of genes involved in the CAV process may offer new insights into pathophysiology and lead to a wider range of therapeutic options.METHODS: This prospective study of 109 patients investigated 44 single nucleotide polymorphisms (SNPs) within the susceptibility loci potentially related to coronary artery disease, carotid artery intima-media thickness (cIMT), and in nitric oxide synthase gene. Genotyping was done by the Fluidigm SNP Type assays and Fluidigm 48.48 Dynamic Array IFC. The intima thickness progression (IT) was evaluated by coronary optical coherence tomography (OCT) performed 1 month and 12 months after heart transplantation (HTx).RESULTS: During the first post-HTx year, the mean intima thickness (IT) increased by 24.0 +/- 34.2 mu m (p < 0.001) and lumen area decreased by -0.9 +/- 1.8 mm2 (p < 0.001). The rs1570360 (A/G) SNP of the vascular endothelial growth factor A (VEGFA) gene showed the strongest association with intima thickness progression, even in the presence of the traditional CAV risk factors. SNPs previously related to carotid artery intima-media thickness rs11785239 (PRAG1), rs6584389 (PAX2), rs13225723 (LINC02577) and rs17477177 (CCDC71L), were among the five most significantly associated with IT progression but lost their significance once traditional CAV risk factors had been added.CONCLUSION: Results of this study suggest that genetic variability may play an important role in CAV development. The vascular endothelial growth factor A gene SNP rs1570360 showed the strongest association with intima thickness (IT) progression measured by OCT, even in the presence of the traditional CAV risk factors (Tab. 3, Fig. 3, Ref. 36). Text in PDF www.elis.sk
Links
MUNI/A/1410/2022, interní kód MUName: Nové trendy v diagnostice a managementu srdečních onemocnění
Investor: Masaryk University, New trends in diagnostics and management of cardiac diseases
PrintDisplayed: 24/7/2024 00:28